Olivet Nazarene University

Digital Commons @ Olivet
Pence-Boyce STEM Student Scholarship
Spring 2020

Measuring the decrement times of volatile anesthetics in
Drosophila melanogaster using gas chromatography-mass
spectrometry
Jason Tolley
jatolley@olivet.edu

Follow this and additional works at: https://digitalcommons.olivet.edu/pence_boyce
Part of the Engineering Commons, Life Sciences Commons, and the Physical Sciences and
Mathematics Commons

Recommended Citation
Tolley, Jason, "Measuring the decrement times of volatile anesthetics in Drosophila melanogaster using
gas chromatography-mass spectrometry" (2020). Pence-Boyce STEM Student Scholarship. 15.
https://digitalcommons.olivet.edu/pence_boyce/15

This Thesis is brought to you for free and open access by Digital Commons @ Olivet. It has been accepted for
inclusion in Pence-Boyce STEM Student Scholarship by an authorized administrator of Digital Commons @ Olivet.
For more information, please contact digitalcommons@olivet.edu.

Determining the decrement times of anesthetics in Drosophila
melanogaster using gas chromatography/mass spectrometry

Jason Tolley
Mentor: Bruce J. Heyen, Ph.D.

Abstract:
Model organisms are widely used in research, especially in the context of complex
situations. One model organism that has been widely used is the common fruit fly, Drosophila
melanogaster (D. mel). D. mel are most commonly used in the context of genetics, but they have
also been widely used in research focusing on general anesthetics. One value that has not been
measured in D. mel, however, as it relates to general anesthetics, is the decrement times. This is
what the present research set out to determine. The anesthetics studied in this research were
isoflurane and sevoflurane. Flies were exposed to 40 µL of anesthetic in a centrifuge tube for 10
minutes, after which the flies were allowed a recovery period of a set time. In the case of the
control group, this time was 0 minutes. The anesthetic was then extracted using dichloromethane
(DCM) and enflurane was added as an internal standard. The decrement times of male flies with
isoflurane were found to be around 30 seconds for the 50% decrement, 2 minutes for the 80%,
and 3 minutes for the 90% decrement. For female flies the values found with isoflurane were
found to be about 30 seconds for the 50% decrement and 4 minutes for the 80% decrement. The
values found for the 50% decrement time of sevoflurane were about 5 minutes for the female
flies and 2 minutes for the male flies, but the values found in female flies with sevoflurane were
not consistent. Though the data with sevoflurane were inconsistent, those collected with
isoflurane give valuable insight into general anesthetics. This information can be used in future
work involving drosophila flies and anesthetics to gain a deeper understanding of how
inhalational anesthetics work.

Introduction:

The first publicized use of anesthetics was nearly 200 years ago in 1846, and since then
the use of anesthetics has become more common and safer for the patient.15,17 There are still
many dangers of anesthetics, however, especially associated with prolonged and early exposure
to anesthetic gases.4,5,12,14,16 Although many discoveries have been made, there are still many
aspects of anesthesia that are not well understood. One way to further understand anesthesia is
through the use of model organisms. A recent discovery that used model organisms found that
stimulation or inhibition of certain neurons in the hypothalamus of mice had a correlation with
quality and duration of sleep.6 To be used as a model organism, research must indicate that the
organism responds to given stimuli in a way similar to how humans respond. This data can then
be used to better understand the stimuli in humans. The fruit fly, Drosophila melanogaster (D.
mel)¸ is commonly used as a model organism, especially in the context of genetics, and has been
said to be the model organism for genetics.13 While genetics is the arena where D. mel has the
most acclaim, the organism can be a model in many other applications.
One application for which D. mel has been used as a model is with anesthetics.
Karunanithi et al. explored how D. mel are similar to humans in the way their minds and bodies
react to anesthetics.7 They present a basic overview of anesthesia and how it affects different
levels of consciousness and discuss a few experiments with anesthetics and D. mel, such as using
propofol-laced food in order to monitor activity of flies with different levels of anesthesia
exposure. In 2017, MacMillan et al. explored the effects of isoflurane and sevoflurane
anesthetics on many different aspects of health in D. mel including fecundity, starvation, and
temperature tolerances.9 MacMillan et al. found that D. mel generally recover more quickly from
sevoflurane than isoflurane after similar exposure times. It was also found that with increased
exposure time, the recovery time was more sex-dependent in isoflurane than in sevoflurane and

that the fecundity of female flies was not significantly affected by either sevoflurane or
isoflurane.
D. mel have been used in many different experiments to determine how anesthesia affects
different organisms and how its effects can change based on genetics and sex.3,7,8,9,10,18 Many
properties of anesthetics have been measured in the organism. One property of anesthetics that is
very important to those who work in the field of anesthesiology is the minimum alveolar content
(MAC). The minimum alveolar content is a measure of how saturated the alveoli in the lungs
must be with an anesthetic before approximately half of all humans will not react to a surgical
incision.11 Zalucki et. al. found the MAC value in D. mel to be 0.2-0.6% depending on the
criteria used to determine if the fly is conscious.18 Consciousness was determined through a
startle response, but the MAC was found to be higher if the test involved what the authors
described to be more complex behavior, such as reacting to a light beam rather than reacting to a
vibration.
One property of anesthetics that has not been measured in D. mel is the decrement times.
The decrement time of an anesthetic is defined as the amount of time necessary for a given
percentage of that anesthetic to have left the organism.11 In 1997, Bailey calculated the
decrement times of isoflurane, sevoflurane, enflurane, and desflurane in humans.2 Bailey found
that after 6 hours of exposure, enflurane has the longest 90% decrement time, at about 100
minutes, with isoflurane at 86 minutes, sevoflurane at 65 minutes, and desflurane being
considerably lower than the rest at 14 minutes.
Knowing the decrement times of different anesthetic gases in D. mel will further establish
the organism as a model for volatile anesthetic properties in humans. In this experiment, the

decrement times of isoflurane and sevoflurane in male and female D. mel will be measured using
gas chromatography-mass spectrometry (GC/MS).

Materials and Methods:
The method for this experiment was largely new, though various other previously
published experiments were consulted in choosing an internal standard, administration of
anesthetic, and deciding the GC/MS method.1,9,10 The flies used were wild type drosophila flies
ordered from Carolina (catalog number 172100). They were kept in culture vials and fed
drosophila fly medium with yeast placed in the media and hydrated using sterile water. Flies
were allowed to propagate and were transferred to new vials every month or so. The vials were
stored in a Fisher Scientific 307C Isotemp Low Temperature Incubator/Freezer set to 21.0 ˚C.
No special attention was paid to using virgin female flies, thus flies were removed from vials and
tested when necessary.
Due to the fact that male and female drosophila flies have been found to have different
recovery times, which would imply different decrement times, the flies were first sorted male
and female.9 This was done by removing flies from the culture vial to a new vial without
medium. Flynap was then administered to the flies until they were all asleep, not exceeding two
minutes of exposure. The flies were then placed on a notecard under a dissection microscope and
sorted into two piles based on sex. Images of male and female flies have been included. It should
also be noted that female flies are typically larger than male flies, but because this can vary based
on genetics, all flies were sexed by flipping the fly over and checking the genitalia.

Image 1. Male drosophila fly. Notice the darker genitals and smaller size.

Image 2. Female drosophila fly. Notice the lighter, smooth genitals and larger size.

After the flies were sorted, they were placed in empty culture vials overnight, to allow
them to recover and to ensure that the Flynap had no effect on responses to the anesthetics being
tested. The following day, the flies were removed from the culture vials into a conical centrifuge
tube. A foam disc was then inserted into the top of the tube, to ensure that the flies would not be
able to escape. Into this foam disc was injected 40 µL of isoflurane or sevoflurane, depending on
which anesthetic was being tested. The cap was placed on the centrifuge tube to keep the
anesthetic inside the tube, and the flies breathed the anesthetic for 10 minutes. At 10 minutes, the

flies were transferred to a glass centrifuge tube, and were either allowed to recover, or, in the
case of the control group, immediately killed by pouring dichloromethane (DCM) into the vial.
At this point, an enflurane internal standard was also added to the vial. The internal standard was
added as soon as possible to ensure any mistakes made during the procedure also affected the
concentration of internal standard. The internal standard solution was made by diluting 40 µL of
enflurane in DCM to a total volume of 10 mL.
The flies were then squished using a glass stir rod, to extract all of the anesthetic from
their bodies by the DCM. This solution was then removed from the vial and diluted to 5 mL, in
order to be sure that every trial was the same volume, no matter how much was removed into the
GC/MS vial.
Before data was collected, the response factor of the internal standard being used,
enflurane, was calculated with both isoflurane and sevoflurane. These were run in equal
concentrations and the following equation was used to calculate response factor (F):
𝐴𝑟𝑒𝑎𝐼𝑆 𝐴𝑟𝑒𝑎𝐴
=
[𝐼𝑆]
[𝐴]
Where “IS” represents the internal standard, and “A” represents the analyte, which was
𝐹∗

either isoflurane or sevoflurane, depending on the trial. Two trials were run for both isoflurane
and sevoflurane, and these values can be found in table 1.
Table 1 The values measured to calculate response factor (F) of isoflurane and sevoflurane with enflurane.
Because equal volumes of internal standard (IS) and analyte were used, the ratio of analyte to IS was equal to F. The
average of the two runs was then calculated for use later.

Trial
Isoflurane 1
Isoflurane 2
Sevoflurane 1
Sevoflurane 2

Analyte
Enflurane
Area Ratio
Peak Area Peak Area
(analyte/IS)
1257948
182306
6.900
1311796
187665
6.990
115502
186218
0.620
120471
190880
0.631

Response
Factor (F) Average F
6.900
6.945
6.990 0.620
0.626
0.631 -

The GC/MS used was a Shimadzu GCMS-QP2010 SE and the column used was a Rtx5MS column of length 30.0 m, diameter 0.25 mm, and thickness 0.25 µm. Many methods and
solvents were tested to find one suitable. The solvent used was dichloromethane (DCM), but
because DCM elutes later than isoflurane, sevoflurane, and enflurane, the mass spectrometer
sensor was turned off around the 2-minute mark to avoid bombarding the sensor. Typically, the
solvent elutes first, thus there is a solvent cut-off time, meaning the sensor waits to turn on until
after the solvent has eluted. But because the solvent eluted later than the compounds being
analyzed, it was decided to turn the sensor off after the analytes were measured.
The method used was adapted from MacMillan et al. and was as follows.11 The column
oven temperature was 30.0 ˚C. The injection temperature was 200.0 ˚C. A split injection mode
was used with a split ratio of 1:50.0. The total flow was set to 54.7 mL/min with a column flow
of 1.01 mL/min. The column oven temperature started at 30.0 ˚C and held at that temperature for
4.00 minutes. The temperature then increased at a rate of 40.00 ˚C/min to a temperature of 140.0
˚C, which was held for 5.00 minutes.

Data and Discussion:
After exposing the flies to anesthetics and extracting them with DCM, the sample was
analyzed by the method described above. The data collected have been compiled below for both
female and male flies and for isoflurane and sevoflurane.
Table 2 Data for isoflurane in female flies. Percent decrement is calculated based on the control group.

Trial
Control
0.5 min recovery
1 min recovery
2 min recovery
3 min recovery

Number Isoflurane Enflurane Amount of
of flies peak area peak area isoflurane
30
15380
5983 1.48x10-3
21
5106
5388 5.46x10-4
30
7097
5447 7.50x10-4
31
3751
5053 4.28x10-4
32
4471
4496 5.73x10-4

Percent
Isoflurane/fly decrement
4.94x10-5
0
-5
2.60x10
47.34
2.50x10-5
49.31
-5
1.38x10
72.05
1.79x10-5
63.73

4 min recovery

26

3350

6305 3.06x10-4

1.18x10-5

76.15

The amount of isoflurane was calculated by using the same equation used to calculate F.
Thus, the value calculated for the 0.5-minute recovery trial was calculated as follows:
𝐹=

(𝐴𝑟𝑒𝑎𝑎𝑛𝑎𝑙𝑦𝑡𝑒 /𝐴𝑟𝑒𝑎𝐼𝑆 )
([𝑎𝑛𝑎𝑙𝑦𝑡𝑒]⁄[𝐼𝑆])

𝐴𝑟𝑒𝑎𝑎𝑛𝑎𝑙𝑦𝑡𝑒
⁄𝐴𝑟𝑒𝑎
𝐼𝑆
[𝑎𝑛𝑎𝑙𝑦𝑡𝑒] = (
)([𝐼𝑆])
𝐹
The value used for the concentration of internal standard ([IS]) was 0.004, because the
internal standard was prepared by diluting 40 µL to 10.00 mL with DCM. The value calculated
for the concentration of anesthetic was then divided by the number of flies in that trial, to
standardize the amount of anesthetic present.
Table 3 Data for isoflurane in male flies. Percent decrement is calculated based on the control group.

Trial
Control
0.5 min
recovery
1 min recovery
2 min recovery
3 min recovery
4 min recovery

Number Isoflurane Enflurane Amount of
of flies peak area peak area isoflurane
29
21681
5739 2.18x10-3
29
21
32
25
23

9010
2816
3978
1689
1414

4958
4505
4598
6202
5607

1.05x10-3
3.60x10-4
4.98x10-4
1.57x10-4
1.45x10-4

Percent
Isoflurane/fly decrement
7.50x10-5
0
3.61x10-5
1.71x10-5
1.56x10-5
6.27x10-6
6.31x10-6

51.90
77.15
79.24
91.64
91.58

Table 4 Data for sevoflurane in female flies. Percent decrement is calculated based on the control group. Notice the
very low percent decrement after 2 minutes of recovery.

Number Sevoflurane Enflurane Amount of
Trial
of flies peak area
peak area sevoflurane
Control
28
4247
5407 5.02x10-3
2 min recovery
30
4905
6011 5.22x10-3
5 min recovery
31
1740
4714 2.36x10-3
8 min recovery
34
2969
4167 4.56x10-3
10 min
recovery
25
0
4707 0

Percent
Sevoflurane/fly decrement
1.79x10-4
0
1.74x10-4
3.04
7.61x10-5
57.55
-4
1.34x10
25.30
0

Table 5 Data for sevoflurane in male flies. Percent decrement is calculated based on the control group.

100

Trial
Control
1 min recovery
2 min recovery
3 min recovery
5 min recovery
7 min recovery

Number Sevoflurane Enflurane Amount of
of flies peak area
peak area sevoflurane Sevoflurane/fly
31
7897
4598 1.10x10-2
3.54x10-4
-3
29
2081
4922 2.70x10
9.32x10-5
27
4277
5918 4.62x10-3
1.71x10-4
39
4560
9534 3.06x10-3
7.84x10-5
-3
32
4619
8626 3.42x10
1.07x10-4
22
0
5304 0
0

Percent
decrement
0
73.68
51.69
77.86
69.80
100

The decrement times of isoflurane and sevoflurane in D. mel have not been measured and
published to date. In order to measure this, male and female flies were separately exposed to 40
µL of isoflurane or sevoflurane for 10 minutes, killed, and the anesthetic was extracted using
dichloromethane. The relative amounts of anesthetic were measured using gas chromatographymass spectrometry, and it was found that the 90% decrement times for isoflurane for male flies
was about 3 minutes. The 50% decrement times were also found to be around 30 seconds for
female flies and slightly less than this for male flies, though an exact number for male flies was
unknown due to the difficulty of extracting the anesthetic that quickly. The highest decrement
times found for isoflurane in the female flies was the 80% decrement time at a little longer than 4
minutes.
The decrement times of sevoflurane are harder to determine based on the data collected.
For female flies, the 50% decrement time was found to be a little under 5 minutes, but with a
recovery time of 8 minutes, the decrement was found to be only 25%. A trial with a recovery
time of 10 minutes using female flies found no sevoflurane peak, so it can be said that the 100%
decrement time is somewhere between 8 minutes and 10 minutes. For male flies using
sevoflurane, the data was similarly inconsistent. Like with the female flies, the only thing that
can be said about the decrement times of sevoflurane in male flies is that the 100% decrement

time is somewhere between 5 minutes and 7 minutes, as no sevoflurane peak was found after a
recovery time of 7 minutes.
One possible reason for the inconsistency in the data for sevoflurane is that sevoflurane
may be metabolized by D. mel in some way that is unknown and that can occur at different rates
under different circumstances. Though the environment during collection of data was never
greatly changed, there may be some unknown factor that caused this change in metabolism.
Conclusion:
As mentioned before, the decrement times of anesthetics in Drosophila melanogaster
have yet to be published, even though D. mel is a common model organism. Though the data
collected using sevoflurane were inconsistent, the values found for isoflurane showed
consistency and would be able to be used in future work involving drosophila flies and
anesthetics to gain a deeper understanding of how inhalational anesthetics work.
This experiment is limited by the fact that the data must be interpreted in the context of
the procedure conducted. That is, the flies were exposed to anesthetic for ten minutes, whereas in
some experiments they may be exposed for much longer than that. The amount of anesthetic the
flies were exposed to, however, saturates the centrifuge tube and makes adding any more
anesthetic superfluous.9 While this does present a challenge when applying this data to other
situations, the data is nonetheless novel and can still be helpful in future research.
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